A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle
Authors
Keywords
Ebola virus, Carbamoyl phosphate synthetase 2 aspartate transcarbamylase and dihydroorotase, De novo pyrimidine synthesis, Dihydroorotate dehydrogenase, Host factor, Teriflunomide, siRNA screen, Non-segmented negative-sense RNA viruses, NNSV
Journal
Genome Medicine
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-27
DOI
10.1186/s13073-018-0570-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication
- (2018) Priya Luthra et al. ANTIVIRAL RESEARCH
- Re-emergence of Lloviu virus in Miniopterus schreibersii bats, Hungary, 2016
- (2018) Gábor Kemenesi et al. Emerging Microbes & Infections
- Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response
- (2017) Nam Nam Cheung et al. JOURNAL OF GENERAL VIROLOGY
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication
- (2017) Andrea Bilger et al. Oncotarget
- Discovery of a Broad-Spectrum Antiviral Compound That Inhibits Pyrimidine Biosynthesis and Establishes a Type 1 Interferon-Independent Antiviral State
- (2016) Dong-Hoon Chung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication
- (2016) Yijin Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems
- (2016) Stephen R. Welch et al. ANTIVIRAL RESEARCH
- The evolution of Ebola virus: Insights from the 2013–2016 epidemic
- (2016) Edward C. Holmes et al. NATURE
- A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Pyrimidine Metabolism: Dynamic and Versatile Pathways in Pathogens and Cellular Development
- (2015) Manuel F. Garavito et al. Journal of Genetics and Genomics
- High-Throughput Minigenome System for Identifying Small-Molecule Inhibitors of Ebola Virus Replication
- (2015) Megan R. Edwards et al. ACS Infectious Diseases
- Reverse genetics systems as tools for the development of novel therapies against filoviruses
- (2014) Thomas Hoenen et al. Expert Review of Anti-Infective Therapy
- Role of Protein Phosphatase 1 in Dephosphorylation of Ebola Virus VP30 Protein and Its Targeting for the Inhibition of Viral Transcription
- (2014) Philipp A. Ilinykh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Life Cycle Modeling System for Ebola Virus Shows a Genome Length-Dependent Role of VP24 in Virus Infectivity
- (2014) A. Watt et al. JOURNAL OF VIROLOGY
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
- (2014) Xiangguo Qiu et al. NATURE
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Cytomegalovirus-mediated activation of pyrimidine biosynthesis drives UDP–sugar synthesis to support viral protein glycosylation
- (2014) Stefanie Renee DeVito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis
- (2013) Manfred Marschall et al. ANTIVIRAL RESEARCH
- A novel Ebola virus expressing luciferase allows for rapid and quantitative testing of antivirals
- (2013) Thomas Hoenen et al. ANTIVIRAL RESEARCH
- DNA Topoisomerase 1 Facilitates the Transcription and Replication of the Ebola Virus Genome
- (2013) K. Takahashi et al. JOURNAL OF VIROLOGY
- Inhibition of Arenavirus by A3, a Pyrimidine Biosynthesis Inhibitor
- (2013) E. Ortiz-Riano et al. JOURNAL OF VIROLOGY
- Inhibition of Pyrimidine Biosynthesis Pathway Suppresses Viral Growth through Innate Immunity
- (2013) Marianne Lucas-Hourani et al. PLoS Pathogens
- Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export
- (2012) Liang Zhang et al. JOURNAL OF CELL BIOLOGY
- Inclusion Bodies Are a Site of Ebolavirus Replication
- (2012) T. Hoenen et al. JOURNAL OF VIROLOGY
- Arenavirus Infection Induces Discrete Cytosolic Structures for RNA Replication
- (2012) N. L. Baird et al. JOURNAL OF VIROLOGY
- GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes, 2013 update
- (2012) Esther E. Schmidt et al. NUCLEIC ACIDS RESEARCH
- High Content Image Based Analysis Identifies Cell Cycle Inhibitors as Regulators of Ebola Virus Infection
- (2012) Krishna P. Kota et al. Viruses-Basel
- The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo
- (2012) Allison Groseth et al. PLoS Pathogens
- Minigenomes, transcription and replication competent virus-like particles and beyond: Reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses
- (2011) Thomas Hoenen et al. ANTIVIRAL RESEARCH
- Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide
- (2011) Melinda C Cox Dunn et al. ANTIVIRAL THERAPY
- Contribution of Sec61α to the Life Cycle of Ebola Virus
- (2011) Ayaka Iwasa et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibition of Dengue Virus through Suppression of Host Pyrimidine Biosynthesis
- (2011) Q.-Y. Wang et al. JOURNAL OF VIROLOGY
- Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV)
- (2011) A. Bonavia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis
- (2011) H.-H. Hoffmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of an Ebolavirus-Like Filovirus in Europe
- (2011) Ana Negredo et al. PLoS Pathogens
- Minigenome-Based Reporter System Suitable for High-Throughput Screening of Compounds Able To Inhibit Ebolavirus Replication and/or Transcription
- (2010) L. D. Jasenosky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficient Budding of the Tacaribe Virus Matrix Protein Z Requires the Nucleoprotein
- (2010) A. Groseth et al. JOURNAL OF VIROLOGY
- Ebola haemorrhagic fever
- (2010) Heinz Feldmann et al. LANCET
- Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes
- (2010) Robin K. Avery et al. TRANSPLANTATION
- Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription
- (2010) T. Hoenen et al. VIROLOGY
- Ebola Virus VP35 Antagonizes PKR Activity through Its C-Terminal Interferon Inhibitory Domain
- (2009) M. Schumann et al. JOURNAL OF VIROLOGY
- Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients
- (2009) Carlos E. Araya et al. PEDIATRIC TRANSPLANTATION
- Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression
- (2009) C. R. Kimberlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Whole-Genome Expression Profiling Reveals That Inhibition of Host Innate Immune Response Pathways by Ebola Virus Can Be Reversed by a Single Amino Acid Change in the VP35 Protein
- (2008) A. L. Hartman et al. JOURNAL OF VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now